Esteves V, Oliveira MAP, Feitosa FS, et al. - The benefits of coronary artery bypass grafting (CABG) and percutaneous coronary intervention are combined in the concept of hybrid coronary revascularization in order to improve the treatment of patients with complex multivessel disease. In this study, the outcomes after hybrid revascularization were compared with those following conventional CABG surgery. Researchers conducted the Myocardial hybrid revascularization vs coronary artERy bypass GraftING for complex triple‐vessel disease—MERGING study, which is a pilot randomized trial, by allocating 60 patients with complex triple‐vessel disease to treatment with hybrid revascularization or conventional CABG (2:1 ratio). Outcomes support the feasibility of hybrid myocardial but it was linked with elevated rates of major adverse cardiovascular events during 2 years of clinical follow‐up, while low rates of complications were encountered in those treated with conventional surgery during the same period. Until there is not enough definitive data, they recommend caution in the application of hybrid revascularization in practice, following a selective case‐by‐case indication